Mitchell Hill

Array ( [id] => 6225315 [patent_doc_number] => 20020004485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Melanocortin receptor antagonists and modulations of melanocortin receptor activity' [patent_app_type] => new [patent_app_number] => 09/849592 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7714 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004485.pdf [firstpage_image] =>[orig_patent_app_number] => 09849592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064109 [patent_doc_number] => 20020032151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation' [patent_app_type] => new [patent_app_number] => 09/848353 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17565 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032151.pdf [firstpage_image] =>[orig_patent_app_number] => 09848353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1140785 [patent_doc_number] => 06777176 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-17 [patent_title] => 'Target system' [patent_app_type] => B1 [patent_app_number] => 09/845225 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 10258 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/777/06777176.pdf [firstpage_image] =>[orig_patent_app_number] => 09845225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6408060 [patent_doc_number] => 20020037851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Human semaphorin L (H-SemaL) and corresponding semaphorins in other species' [patent_app_type] => new [patent_app_number] => 09/836077 [patent_app_country] => US [patent_app_date] => 2001-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19579 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037851.pdf [firstpage_image] =>[orig_patent_app_number] => 09836077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828641 [patent_doc_number] => 20020068366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Proteomic analysis by parallel mass spectrometry' [patent_app_type] => new [patent_app_number] => 09/835273 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10342 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068366.pdf [firstpage_image] =>[orig_patent_app_number] => 09835273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7451689 [patent_doc_number] => 20040010134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Albumin fusion proteins' [patent_app_type] => new [patent_app_number] => 09/833245 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 181278 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010134.pdf [firstpage_image] =>[orig_patent_app_number] => 09833245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6889573 [patent_doc_number] => 20010025028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Methods of inhibiting bone resorption' [patent_app_type] => new [patent_app_number] => 09/833185 [patent_app_country] => US [patent_app_date] => 2001-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7075 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20010025028.pdf [firstpage_image] =>[orig_patent_app_number] => 09833185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6342496 [patent_doc_number] => 20020034802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Crystals of the alpha 1 beta 1 integrin I-domain and their use' [patent_app_type] => new [patent_app_number] => 09/826716 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10024 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034802.pdf [firstpage_image] =>[orig_patent_app_number] => 09826716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5907947 [patent_doc_number] => 20020142952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Polynucleotides encoding novel secreted proteins' [patent_app_type] => new [patent_app_number] => 09/822830 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26633 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142952.pdf [firstpage_image] =>[orig_patent_app_number] => 09822830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6306052 [patent_doc_number] => 20020094540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'N-TRADD active site and uses thereof' [patent_app_type] => new [patent_app_number] => 09/821819 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 13412 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094540.pdf [firstpage_image] =>[orig_patent_app_number] => 09821819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 899367 [patent_doc_number] => 07343246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Spatial profiling of proteins using hydrophobic moments' [patent_app_type] => utility [patent_app_number] => 09/818461 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 6131 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/343/07343246.pdf [firstpage_image] =>[orig_patent_app_number] => 09818461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1220415 [patent_doc_number] => 06703238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-09 [patent_title] => 'Methods for expanding antigen-specific T cells' [patent_app_type] => B2 [patent_app_number] => 09/812528 [patent_app_country] => US [patent_app_date] => 2001-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 16334 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703238.pdf [firstpage_image] =>[orig_patent_app_number] => 09812528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838753 [patent_doc_number] => 20030036093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Methods of ab initio prediction of alpha helices, beta sheets, and polypeptide tertiary structures' [patent_app_type] => new [patent_app_number] => 09/788006 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 30999 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036093.pdf [firstpage_image] =>[orig_patent_app_number] => 09788006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5800860 [patent_doc_number] => 20020009454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Composition and method for treating inflammatory diseases' [patent_app_type] => new [patent_app_number] => 09/784623 [patent_app_country] => US [patent_app_date] => 2001-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 27800 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20020009454.pdf [firstpage_image] =>[orig_patent_app_number] => 09784623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6342555 [patent_doc_number] => 20020034808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Crystal of bacterial core RNA polymerase' [patent_app_type] => new [patent_app_number] => 09/782714 [patent_app_country] => US [patent_app_date] => 2001-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20715 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034808.pdf [firstpage_image] =>[orig_patent_app_number] => 09782714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231671 [patent_doc_number] => 06693083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Conjugates targeted to the interleukin-2 receptor' [patent_app_type] => B2 [patent_app_number] => 09/782385 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10328 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693083.pdf [firstpage_image] =>[orig_patent_app_number] => 09782385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5873852 [patent_doc_number] => 20020048772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Protein design automation for protein libraries' [patent_app_type] => new [patent_app_number] => 09/782004 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 32315 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048772.pdf [firstpage_image] =>[orig_patent_app_number] => 09782004 [rel_patent_id] =>[rel_patent_doc_number] =>)